List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.5. Antiretrovirals | No observations |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.5. Antiretrovirals | No observations |
El Salvador - 2019 | ANTIVIRALES DE USO SISTÉMICO | No observations |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.5. Antiretrovirals | No observations |
Peru | 6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors | No observations |
Suriname. NGK-C-011 | 29.1 Antiretrovirals | No observations |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.5. Antiretrovirals | No observations |
Peru | 6.4.2.1 Nucleoside Reverse Transcriptase Inhibitors | No observations |
El Salvador - 2019 | ANTIVIRALES DE USO SISTÉMICO | No observations |
List | Section | Observation |
---|---|---|
Ecuador | Essential Medicines List - Ecuador | No observations |
List | Section | Observation |
---|---|---|
Suriname. NGK-C-011 | 6.12 Antiretrovirals | No observations |
Barbados. Barbados National Drug Formulary (BNDF) | 08.18.08.20 Nucleoside Reverse Transcriptase Inhibitors | No observations |